Mehul Shah's insights for Rising input costs, export slump take a toll on drug companies health with ET Pharma

Our Founder, Mehul Shah, recently shared his insights on this matter with ET Pharma. The industry now faces a delayed recovery , with inventory overhang from the March surge, a 0.6% price cap on essential medicines, and sustained cost pressure from freight and raw material inflation. Link: https://lnkd.in/gwsQkYAX